Ethiopia malaria study raises alarm on drug resistance
NCT ID NCT07527182
First seen Apr 28, 2026 · Last updated May 18, 2026 · Updated 5 times
Summary
This study looked at whether the malaria parasite in Ethiopia is becoming resistant to artemisinin, the main drug used to treat it. Researchers tested 277 people with malaria across five sites, checking if parasites were still in their blood three days after treatment. They also looked for a specific genetic marker linked to resistance. The goal was to confirm if drug resistance is a real problem in Ethiopia, which could affect how malaria is treated in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG RESISTANCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bako Health Center
Bako, Ethiopia
-
Mehoni Health Center
Mersa, Tigray, Ethiopia
-
Metahara Health Center
Metehara, Ethiopia
-
Rama Health Center
Rama, Ethiopia
-
Workamba Health Center
Kechemo, Ethiopia
Conditions
Explore the condition pages connected to this study.